Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Chronic Active Antibody Mediated Rejection After Kidney Transplantation by Double-Filtration PlasmaPheresis (DFPP) or Plasma Exchange (PE).

NCT03436134 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT03436134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03436134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Chronic Active Antibody Mediated Rejection After Kidney Transplantation by Double-Filtration PlasmaPheresis (DFPP) or Plasma Exchange (PE).
Lead sponsor
University Hospital, Grenoble
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2018
Completion date
March 1, 2021
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibody mediated rejection, kidney transplantation